Journal
MOLECULAR PSYCHIATRY
Volume 15, Issue 2, Pages 204-215Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/mp.2009.58
Keywords
schizophrenia; DTNBP1; pallidin; synaptosomal-associated protein; biological plausibility; neurite extension
Funding
- National Institutes of Health [HL068117]
- NARSAD: The Mental Health Research Association
Ask authors/readers for more resources
Previous studies have implicated DTNBP1 as a schizophrenia susceptibility gene and its encoded protein, dysbindin, as a potential regulator of synaptic vesicle physiology. In this study, we found that endogenous levels of the dysbindin protein in the mouse brain are developmentally regulated, with higher levels observed during embryonic and early postnatal ages than in young adulthood. We obtained biochemical evidence indicating that the bulk of dysbindin from brain exists as a stable component of biogenesis of lysosome-related organelles complex-1 (BLOC-1), a multi-subunit protein complex involved in intracellular membrane trafficking and organelle biogenesis. Selective biochemical interaction between brain BLOC-1 and a few members of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) superfamily of proteins that control membrane fusion, including SNAP-25 and syntaxin 13, was demonstrated. Furthermore, primary hippocampal neurons deficient in BLOC-1 displayed neurite outgrowth defects. Taken together, these observations suggest a novel role for the dysbindin-containing complex, BLOC-1, in neurodevelopment, and provide a framework for considering potential effects of allelic variants in DTNBP1-or in other genes encoding BLOC-1 subunits-in the context of the developmental model of schizophrenia pathogenesis. Molecular Psychiatry (2010) 15, 204-215; doi: 10.1038/mp.2009.58; published online 23 June 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available